COMMUNIQUÉS West-GlobeNewswire

Coherus BioSciences Announces New Employment Inducement Grants
19/12/2018
REDWOOD CITY, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective December 18, 2018, the compensation committee of the company’s board of directors granted [...]
ADMA Biologics Provides Regulatory Update for BIVIGAM®
19/12/2018
FDA PDUFA Action Anticipated RAMSEY, N.J. and BOCA RATON, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), announces that as of the time of this press release the [...]
Eyenovia Prices Public Offering of Common Stock
19/12/2018
NEW YORK, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (“Eyenovia” or the “Company”) (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing [...]
Hemp Legalization Bodes Well for Alkaline Water Co. -- CFN Media
19/12/2018
SEATTLE, Dec. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Phoenix Life Sciences International Announces Doctor Mohyuddin Mirza as Company's New Botany Specialist
19/12/2018
DENVER, CO, Dec. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that [...]
CV Sciences, Inc. Featured as a Panelist at 2nd Annual Neuroscience Innovation Forum in San Francisco
19/12/2018
Forum to cover partnerships, industry keynotes and influential medical panels LAS VEGAS, Dec. 19, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB: CVSI) preeminent supplier and manufacturer of its industry dominating [...]
Teladoc Health to Participate in Upcoming Investor Conference
19/12/2018
PURCHASE, NY, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Jason Gorevic, chief executive officer, will participate in the following [...]
Matinas BioPharma Appoints Harold E. Bays, M.D. to its Cardiovascular Health Scientific Advisory Board
19/12/2018
Well known and highly regarded clinical leader having served as an Investigator for over 500 Phase 1 - 4 clinical trials evaluating treatments for dyslipidemia, obesity, diabetes mellitus, hypertension, and other [...]
John H. Johnson Agrees to Become Permanent Chief Executive Officer of Melinta Therapeutics
19/12/2018
NEW HAVEN, Conn., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, today [...]
Biome Grow Secures Sales License for Nova Scotia Subsidiary-- CFN Media
19/12/2018
SEATTLE, Dec. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Avricore Health Signs Letter of Intent with Molecular You to Further Enhance the HealthTab Platform with Tests Designed to Ensure Safe Cannabis Use
19/12/2018
VANCOUVER, British Columbia, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) (“ Avricore Health ”) is pleased to announce that it has signed a Letter of Intent (LOI) with Molecular You Corporation [...]
Hemispherx Biopharma Inc. Announces First Large Ampligen Shipment to a Clinical Site for Use in U.S. Expanded Access Program
19/12/2018
OCALA, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology, shipped 720 [...]
Resverlogix Announces Eighth Positive Data Safety Monitoring Board Recommendation For Phase 3 Study of Apabetalone
19/12/2018
BETonMACE trial to continue as planned without modification CALGARY, Alberta, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) today announces the independent Data and [...]
NexTech Launches Ecommerce AR Solution for Shopify, Magento & WordPress -- CFN Media
19/12/2018
SEATTLE, Dec. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Melinta Therapeutics Announces Commitment for New Credit Facility of Up to $135 Million
19/12/2018
~ Credit Facility has Option to be Converted into Preferred Shares ~ ~ Adjourns Special Meeting of Stockholders Scheduled for December 20, 2018 ~ ~ Reaffirms Product Sales and Cost Savings Guidance ~ NEW HAVEN, Conn., [...]
Tabula Rasa HealthCare Appoints Kevin Boesen as Chief Sales Officer
19/12/2018
MOORESTOWN, N.J., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced the appointment of [...]
Equillium Granted U.S. FDA Fast Track Designation for EQ001 for the Treatment of Acute Graft-Versus-Host Disease
19/12/2018
Company plans to initiate Phase 1b/2 EQUATE clinical trial in early 2019 LA JOLLA, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immuno- [...]
Evolus Added to NASDAQ Biotechnology Index
19/12/2018
IRVINE, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced that the company has been selected for addition to the NASDAQ Biotechnology Index [...]
Spectral to Attend the 37th Annual J.P. Morgan Healthcare Conference
19/12/2018
TORONTO, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT) , a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a [...]

Pages